Ryan Allway June 1st, 2022 Psychedelics, Top News The patent was granted by India’s Office of the Controller-General of Patents, Designs and Trademarks VANCOUVER, June 1, 2022– Clearmind Medicine Inc. (CSE: CMND, OTC Pink: CMNDF, FSE: CWY0) (“Clearmind” or the “Company“), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics... Read more